Literature DB >> 14966181

The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis.

S M Leary, A J Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14966181      PMCID： PMC1738962          DOI： 10.1136/jnnp.2003.018598

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  2 in total

1.  Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice.

Authors:  Peter Joseph Jongen; Christian Sindic; Evert Sanders; Stanley Hawkins; Wim Linssen; Erik van Munster; Stephan Frequin; George Borm
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

Review 2.  Spasticity in multiple sclerosis and role of glatiramer acetate treatment.

Authors:  Jose Eustasio Meca-Lallana; Rocío Hernández-Clares; Ester Carreón-Guarnizo
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.